Clomiphene Citrate 25mg for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Oct 2026: Trial registered, NCT07882862

The trials

NCT07882862: HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate Cancer

State
Not started
Phase
Phase 2
People
83 planned
Started
31 Jan 2027
Primary completion
30 Jun 2029
Arms
Cohort A - oral clomiphene citrate, 25 mg, once daily for 6 months
Results
None posted
  1. 20 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.